Willis Johnson & Associates’s Exelon EXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-17,480
Closed -$709K – 162
2024
Q3
$709K Hold
17,480
– – 0.05% 76
2024
Q2
$605K Hold
17,480
– – 0.05% 81
2024
Q1
$657K Buy
17,480
+170
+1% +$6.08K 0.06% 70
2023
Q4
$621K Buy
17,310
+163
+1% +$6.28K 0.06% 68
2023
Q3
$648K Buy
17,147
+139
+0.8% +$5.66K 0.07% 70
2023
Q2
$693K Buy
17,008
+81
+0.5% +$3.35K 0.07% 68
2023
Q1
$709K Buy
16,927
+215
+1% +$8.96K 0.08% 68
2022
Q4
$722K Buy
+16,712
New +$660K 0.09% 65

Other funds holding EXC

Willis Johnson & Associates's EXC Position: Q4 2024 in Review

Willis Johnson & Associates sold out of Exelon (EXC) in Q4 2024, closing a stake of 17,480 shares — an estimated $709K sold.

Willis Johnson & Associates first reported a position in EXC in Q4 2022 and held it in 8 quarters. The position peaked at $722K in Q4 2022. 1,103 funds tracked by Wall St. Rank hold EXC as of Q4 2024.

  • Willis Johnson & Associates reported no remaining Exelon position as of Q4 2024 after selling out during the quarter.
  • Willis Johnson & Associates sold 17,480 Exelon shares in Q4 2024, an estimated $709K.
  • Willis Johnson & Associates first reported a position in Exelon in Q4 2022 and held it in 8 quarters.
  • Willis Johnson & Associates's Exelon position peaked at $722K in Q4 2022.
  • 1,103 funds tracked by Wall St. Rank held Exelon as of Q4 2024.

Based on Willis Johnson & Associates's 13F filing for Q4 2024, filed 14 Feb 2025.